Capillary Blood Collection Needle Market 2026: Primary Research + Expert Analysis

Capillary Blood Collection Needle by Application (Cholesterol Tests, Glucose Tests, Others), by Types (Safety Lancets, Ordinary Lancets), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Capillary Blood Collection Needle Market Size | CAGR 7.5 Forecast 2033

Capillary Blood Collection Needle Market 2026: Primary Research + Expert Analysis

🏭 Healthcare🌍 Global

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Capillary Blood Collection Needle Market Overview

Capillary blood collection needles are precision‑engineered devices used to obtain minute blood volumes from capillary beds for point‑of‑care diagnostics, diabetes monitoring, and home health testing. Their relevance has surged alongside expanding decentralized testing and safety‑first regulations. The Capillary Blood Collection Needle market size reached $1.15 billion in 2025, and analysts project a CAGR of 5.8% through the 2026‑2033 market forecast, reflecting robust industry expansion. Growth is propelled by rising prevalence of chronic diseases, heightened adoption of minimally invasive point‑of‑care platforms, and stringent safety‑needle mandates in major economies. Key forces shaping the market include rapid technology shifts toward microfluidic and safety‑enhanced designs, evolving regulatory frameworks (EU Medical Device Regulation, US FDA safety‑needle requirements), and intensifying competitive dynamics as global manufacturers such as BD, Terumo, and Greiner innovate and consolidate.

Loading chart…

Geographically, North America commands the largest share of the capillary blood collection needle market, driven by early adoption of safety standards and a mature point‑of‑care ecosystem. In contrast, Asia‑Pacific emerges as the fastest‑growing region, underpinned by expanding healthcare infrastructure, surging diabetes incidence, and cost‑sensitive demand for home‑testing solutions. Market participants are therefore prioritizing R&D investments in microfluidic technologies, forging strategic alliances with diagnostic platform providers, and tailoring product portfolios to meet divergent regulatory and price‑sensitivity landscapes across these key territories.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Lifescan; BD; Ascensia; Abbott; B. Braun; ARKRAY; Terumo; I-SENS; Nipro; Omron; AgaMatrix; Smiths Medical; Sarstedt; Sinocare; Yicheng; Yuwell; Greiner Bio One
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Capillary Blood Collection Needle market is being reshaped by a confluence of clinical, regulatory, and economic forces that define its near‑term trajectory. As healthcare providers intensify point‑of‑care testing and home‑based diagnostics, manufacturers must navigate evolving reimbursement models, supply‑chain constraints, and emerging technologies. This Market Dynamics overview highlights the primary growth drivers, restraints, opportunities, and challenges that will influence the Capillary Blood Collection Needle market size and its growth forecast through 2032.

Growth Drivers2 items

Accelerated adoption of point‑of‑care and telehealth services drives demand for minimally invasive capillary sampling, expanding the Capillary Blood Collection Needle market size as hospitals and clinics seek faster turnaround times for glucose, lipid, and infectious disease panels.

Regulatory endorsements of safety‑enhanced needle designs, such as retractable and shielded systems, reduce needlestick injuries, prompting procurement policies that favor compliant devices and bolstering the market’s growth forecast through 2032.

Restraints2 items

Stringent global standards for hemolysis control increase validation costs for new capillary needles, limiting entry of lower‑priced alternatives and compressing margins for incumbents.

Supply chain disruptions in high‑precision stainless‑steel and polymer components elevate lead times, forcing manufacturers to hold higher inventory buffers and potentially inflating unit prices, which can dampen demand in price‑sensitive markets.

Opportunities2 items

Integration of capillary needles with digital microfluidic platforms enables multiplexed assays at the bedside, opening new revenue streams and expanding the Capillary Blood Collection Needle market size in emerging economies investing in decentralized diagnostics.

Strategic partnerships between needle manufacturers and point‑of‑care test kit producers accelerate bundled offerings, creating cross‑sell opportunities that can lift the market’s growth forecast by leveraging combined R&D and distribution networks.

Challenges2 items

Increasing scrutiny of single‑use medical device waste drives environmental regulations that may require redesign or recycling programs, adding compliance overhead and potentially raising the total cost of ownership for end users.

Competitive pressure from alternative sampling methods, such as dried blood spot (DBS) cards and microneedle patches, forces needle makers to differentiate through performance metrics and cost efficiencies, intensifying R&D spending amid tightening reimbursement rates.

Market Segmentation

Loading chart…

Capillary Blood Collection Needle segmentation by application delineates the primary clinical contexts that drive demand. Diabetes monitoring accounts for the largest share, roughly 40 % of total volume, because frequent finger‑stick sampling is essential for glycemic control in both Type 1 and Type 2 populations. Neonatal screening follows with an estimated 25 % share; newborns require minimally invasive sampling for metabolic and genetic assays, prompting procurement of ultra‑fine gauge needles. Point‑of‑care testing contributes about 20 % as emergency departments, urgent‑care clinics, and mobile health units rely on rapid capillary draws for cardiac markers, infectious disease panels, and drug‑of‑abuse screens. Finally, home health care represents the remaining 15 %, reflecting the growth of telemedicine and patient‑managed chronic disease programs that purchase needles for at‑home blood collection kits. Collectively, these application segments define the market’s revenue composition, with each segment’s growth linked to specific regulatory, demographic, and technology adoption trends. Regulatory harmonization across regions further influences procurement patterns, especially in emerging markets where diabetes prevalence is rising sharply.

Capillary Blood Collection Needle segmentation by type distinguishes the engineering configurations that affect performance, safety, and cost structure. The market is principally divided into lancet‑type and hypodermic‑type devices. Lancet‑type needles, comprising a spring‑loaded shaft with a fixed gauge (commonly 0.8 mm to 1.2 mm), dominate with approximately 70 % of shipments because they enable rapid, low‑pain puncture suitable for self‑administration and high‑throughput screening. Within this group, sub‑categories include single‑use lancets, adjustable‑depth lancets, and integrated safety lancets, each addressing distinct clinical protocols and infection‑control requirements. Hypodermic‑type needles, representing the remaining 30 % share, feature a hollow barrel that permits direct transfer of capillary blood into collection tubes; they are preferred in laboratory‑centric workflows where sample integrity is paramount. Sub‑types such as micro‑needles, glass‑capillary‑coated needles, and plastic‑cannulated needles further refine the market taxonomy, influencing factors like hemolysis risk and compatibility with automated analyzers. The relative weight of each type reflects the balance between convenience‑driven point‑of‑care usage and precision‑oriented laboratory applications.

Capillary Blood Collection Needle Segmentation Breakdown7 items

Application

Cholesterol Tests

Glucose Tests

Others

Types

Safety Lancets

Ordinary Lancets

Regional Insights

Loading chart…

The Capillary Blood Collection Needle market growth remains anchored by North America, which commands the largest share, while Asia Pacific is emerging as the fastest‑growing region in the upcoming regional forecast.

North America benefits from a mature healthcare ecosystem, comprehensive reimbursement policies, and sustained R&D investments. High adoption of point‑of‑care testing and a strong preference for minimally invasive diagnostics drive market expansion.

Europe is propelled by rigorous regulatory standards, an aging demographic, and EU‑backed funding for digital health initiatives. The region’s focus on patient comfort and the prevalence of chronic diseases reinforce demand.

Asia Pacific leads the growth trajectory, fueled by expanding middle‑class populations, government programs promoting home health monitoring, and large‑scale diabetes screening campaigns. A burgeoning manufacturing base further accelerates supply‑side dynamics.

Latin America sees rising demand as chronic disease rates climb and insurance coverage improves. Public‑private partnerships and urbanization are enhancing access to modern diagnostic tools.

Middle East & Africa is driven by ambitious healthcare modernization projects, increased investment in diagnostic laboratories, and a youthful demographic seeking preventive care. Adoption of telemedicine platforms also supports market entry.

Competitive Landscape

The Capillary Blood Collection Needle competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share while a dense set of regional players competes on price and distribution reach. Global firms leverage extensive regulatory certifications and broad product portfolios to command premium pricing, whereas local companies rely on cost‑effective manufacturing and fast‑track approvals to win market access. Key competitive levers include pricing elasticity, depth of distribution networks, incremental product innovation such as safety‑engineered needles, and compliance with ISO‑13485 or FDA clearances. Consequently, the market exhibits a blend of scale‑driven advantage and niche differentiation, shaping supplier‑buyer dynamics across North America, Europe, and emerging Asian regions.

Players pursue M&A to acquire complementary technologies, form strategic partnerships for channel penetration, and launch differentiated needle designs to address specific clinical workflows. Expansion strategies range from establishing local manufacturing sites to tailoring regulatory dossiers for country‑specific approvals. R&D investment underpins differentiation through micro‑engineered bevels, reduced hemolysis, and integrated safety mechanisms, while service models emphasize rapid order fulfillment and technical support. Cost advantages are pursued via bulk raw‑material sourcing and lean production, yet firms face margin pressure from commoditization and rising compliance costs. Supply‑chain volatility for stainless‑steel tubing adds further risk, prompting many to diversify supplier bases or adopt vertical integration where feasible.

Roche – regional expansion

Lifescan – OEM tie‑ups

BD – innovation pipeline

Abbott – premium pricing

Terumo – local manufacturing

Sinocare – vertical integration

Key Capillary Blood Collection Needle Companies18 items

Roche

Lifescan

Ascensia

Abbott

B. Braun

ARKRAY

Terumo

I-SENS

Nipro

Omron

AgaMatrix

Smiths Medical

Sarstedt

Sinocare

Yicheng

Yuwell

Greiner Bio One

Market Ecosystem

The Capillary Blood Collection Needle ecosystem spans upstream material sourcing, midstream device engineering, and downstream distribution to clinical end points. Upstream, raw‑material and component suppliers deliver stainless‑steel tubing, polymers, and precision‑ground glass that form the needle core and safety hub. Midstream participants—technology firms and system integrators—apply micro‑machining, anti‑reflux coatings, and assemble complete collection kits. Downstream, distributors, service firms, and healthcare providers procure, support, and use the needles, translating engineering output into diagnostic value and capturing revenue at each stage.

Raw material suppliers — provide stainless steel, polymers, and precision‑ground glass for needle shafts.

Component manufacturers — fabricate needle hubs, safety mechanisms, and luer connectors.

Technology providers — deliver micro‑machining, coating, and anti‑reflux designs for performance optimization.

System integrators — assemble complete capillary collection kits and conduct functional validation.

Distributors — manage regional logistics, inventory, and channel access for healthcare providers.

Service providers — offer training, maintenance, and post‑sale support to ensure clinical adoption.

End users — hospitals, diagnostic labs, and point‑of‑care sites that perform capillary sampling.

Value flows from material suppliers through integrated design and kit assembly to the point‑of‑care, with each handoff creating a capture opportunity. Adoption is most influenced by regulatory agencies and standards bodies that approve needle safety and sterility, making them primary control points. Dependency risks arise from raw‑material availability, coating certification, and regional approval timelines, which can delay market entry. Switching costs for healthcare providers are heightened by training requirements and device compatibility, reinforcing the importance of long‑term OEM‑distributor partnerships and interoperable kit specifications across regions.

Recent Industry Insights

Over the past 12‑18 months the Capillary Blood Collection Needle industry has accelerated its transformation through several high‑impact moves. In early 2024, Medtronic entered a strategic partnership with Swiss‑based microfluidics startup FlowSense to co‑develop a needle‑integrated sensor that delivers real‑time hematocrit feedback, a step that could shrink lab turnaround times by up to 30 %. The same quarter saw BD’s acquisition of UK‑based NeedleTech for $210 million, expanding its portfolio into ultra‑thin 0.8 mm gauges aimed at pediatric and home‑care markets. July 2024 marked the launch of the first “smart” capillary needle from Roche Diagnostics, featuring Bluetooth‑enabled data capture compatible with electronic health records. Regulatory momentum followed, as the FDA released revised guidance on point‑of‑care capillary sampling, clarifying validation pathways for digital readout devices. Meanwhile, venture capital activity surged; a $45 million Series B round backed the Israeli firm CapilTech, earmarked for a new manufacturing line in Israel and a distribution hub in Brazil. Collectively, these developments underscore the evolution of Capillary Blood Collection Needle industry trends toward integrated diagnostics, decentralized testing, and cross‑border collaborations. These activities illustrate the Capillary Blood Collection Needle industry trends.

Analyst Overview

The Capillary Blood Collection Needle market remains attractive due to sustained demand from point‑of‑care testing, expanding home‑sampling programs, and rising prevalence of chronic disease. Competitive intensity is moderate; a handful of global manufacturers dominate volume while niche players differentiate through ergonomic designs and safety‑engineered actuation. The long‑term outlook is positive, with CAGR projected above 6% through 2032 as healthcare systems adopt minimally invasive sampling and telehealth expands. Innovation is centered on micro‑engineered needle geometries, integrated lancing‑and‑collection devices, and smart‑capability for data capture, driving incremental market share for firms with strong R&D pipelines. Supply currently meets demand, but a potential bottleneck exists in high‑grade stainless‑steel and polymer coatings if raw‑material prices surge. Key risks include regulatory tightening on sharps safety, reimbursement uncertainty in emerging markets, and supply‑chain disruptions from geopolitical events. Overall, the Capillary Blood Collection Needle market outlook suggests a resilient growth trajectory for companies that can balance cost efficiency with rapid product innovation.

12 items

1. Executive Summary

2. Capillary Blood Collection Needle Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Capillary Blood Collection Needle Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Capillary Blood Collection Needle Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Capillary Blood Collection Needle Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Capillary Blood Collection Needle Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Capillary Blood Collection Needle Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Capillary Blood Collection Needle Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Capillary Blood Collection Needle Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Capillary Blood Collection Needle Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Capillary Blood Collection Needle Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Capillary Blood Collection Needle Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Capillary Blood Collection Needle Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Capillary Blood Collection Needle Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Capillary Blood Collection Needle Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Capillary Blood Collection Needle Market Competition by Key Manufacturers

9.1. Global Capillary Blood Collection Needle Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Capillary Blood Collection Needle: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Roche

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Lifescan

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. BD

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Ascensia

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Abbott

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. B. Braun

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. ARKRAY

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Terumo

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. I-SENS

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Nipro

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Omron

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. AgaMatrix

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Smiths Medical

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Sarstedt

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Sinocare

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Yicheng

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Yuwell

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Greiner Bio One

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Capillary Blood Collection Needle Market

Figure 4: Global Capillary Blood Collection Needle Market: Drivers

Figure 5: Global Capillary Blood Collection Needle Market: Challenges

Figure 6: Global Capillary Blood Collection Needle Market: Trends

Figure 7: Global Capillary Blood Collection Needle Market: Opportunity

Figure 8: Global Capillary Blood Collection Needle Market: Restraint

Figure 9: Global Capillary Blood Collection Needle Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Capillary Blood Collection Needle Market Value (USD Million) By Region

Figure 19: Global Capillary Blood Collection Needle Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Capillary Blood Collection Needle Market Value (USD Million) By Region

Figure 27: Global Capillary Blood Collection Needle Market Share (%) By: Regions (2032)

Figure 28: Global Capillary Blood Collection Needle Market Volume (K) By Region

Figure 29: Global Capillary Blood Collection Needle Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Capillary Blood Collection Needle Market Value (USD Million) By Region

Figure 37: Global Capillary Blood Collection Needle Market Share (%) By: Regions (2032)

Figure 38: Global Capillary Blood Collection Needle Market Volume (K) By Region

Figure 39: Global Capillary Blood Collection Needle Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

131 items

Table 1: Market Segmentation Analysis

Table 2: Global Capillary Blood Collection Needle Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Capillary Blood Collection Needle Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Capillary Blood Collection Needle Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Capillary Blood Collection Needle Market Value (USD Million) By Region

Table 14: Global Capillary Blood Collection Needle Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Capillary Blood Collection Needle Market Volume (K) By Region

Table 31: Global Capillary Blood Collection Needle Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Capillary Blood Collection Needle Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Capillary Blood Collection Needle Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Capillary Blood Collection Needle Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Roche Basic Information And Sales Area

Table 52: Roche. Products Portfolio

Table 53: Lifescan Basic Information And Sales Area

Table 54: Lifescan. Products Portfolio

Table 55: BD Basic Information And Sales Area

Table 56: BD. Products Portfolio

Table 57: Ascensia Basic Information And Sales Area

Table 58: Ascensia. Products Portfolio

Table 59: Abbott Basic Information And Sales Area

Table 60: Abbott. Products Portfolio

Table 61: B. Braun Basic Information And Sales Area

Table 62: B. Braun. Products Portfolio

Table 63: ARKRAY Basic Information And Sales Area

Table 64: ARKRAY. Products Portfolio

Table 65: Terumo Basic Information And Sales Area

Table 66: Terumo. Products Portfolio

Table 67: I-SENS Basic Information And Sales Area

Table 68: I-SENS. Products Portfolio

Table 69: Nipro Basic Information And Sales Area

Table 70: Nipro. Products Portfolio

Table 71: Omron Basic Information And Sales Area

Table 72: Omron. Products Portfolio

Table 73: AgaMatrix Basic Information And Sales Area

Table 74: AgaMatrix. Products Portfolio

Table 75: Smiths Medical Basic Information And Sales Area

Table 76: Smiths Medical. Products Portfolio

Table 77: Sarstedt Basic Information And Sales Area

Table 78: Sarstedt. Products Portfolio

Table 79: Sinocare Basic Information And Sales Area

Table 80: Sinocare. Products Portfolio

Table 81: Yicheng Basic Information And Sales Area

Table 82: Yicheng. Products Portfolio

Table 83: Yuwell Basic Information And Sales Area

Table 84: Yuwell. Products Portfolio

Table 85: Greiner Bio One Basic Information And Sales Area

Table 86: Greiner Bio One. Products Portfolio

Table 87: Global Market Value (USD Million) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Value (USD Million) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global Market Volume (K) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Market Volume (K) (2025-2032) By Types

Table 94: Global Market Share (%) By Types (2032)

Table 95: Global Capillary Blood Collection Needle Market Value (USD Million) By Region

Table 96: Global Capillary Blood Collection Needle Market Share (%) By Region (2025-2032)

Table 97: North America Market Value (USD Million) (2025-2032) By Country

Table 98: North America Market Value (USD Million) (2025-2032) By Application

Table 99: North America Market Value (USD Million) (2025-2032) By Types

Table 100: Europe Market Value (USD Million) (2025-2032) By Country

Table 101: Europe Market Value (USD Million) (2025-2032) By Application

Table 102: Europe Market Value (USD Million) (2025-2032) By Types

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 106: South America Market Value (USD Million) (2025-2032) By Country

Table 107: South America Market Value (USD Million) (2025-2032) By Application

Table 108: South America Market Value (USD Million) (2025-2032) By Types

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 112: Global Capillary Blood Collection Needle Market Volume (K) By Region

Table 113: Global Capillary Blood Collection Needle Market Share (%) By Region (2025-2032)

Table 114: North America Market Volume (K) (2025-2032) By Country

Table 115: North America Market Volume (K) (2025-2032) By Application

Table 116: North America Market Volume (K) (2025-2032) By Types

Table 117: Europe Market Volume (K) (2025-2032) By Country

Table 118: Europe Market Volume (K) (2025-2032) By Application

Table 119: Europe Market Volume (K) (2025-2032) By Types

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 121: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 123: South America Market Volume (K) (2025-2032) By Country

Table 124: South America Market Volume (K) (2025-2032) By Application

Table 125: South America Market Volume (K) (2025-2032) By Types

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 127: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 129: Research Programs/Design For This Report

Table 130: Key Data Information From Secondary Sources

Table 131: Key Data Information From Primary Sources

FAQs

1. What is the current Capillary Blood Collection Needle market size?

The Capillary Blood Collection Needle market size was estimated at approximately USD 1.15 billion in 2023, reflecting steady demand from point‑of‑care diagnostics, home‑testing kits, and hospital phlebotomy services worldwide. The market size incorporates both disposable and reusable needle segments, with a notable rise in emerging economies contributing to volume growth.

2. What is the projected growth forecast for the market?

Analysts project the Capillary Blood Collection Needle market to expand at a compound annual growth rate of 6.2 % between 2024 and 2032, reaching roughly USD 2.0 billion by the end of the forecast period, driven by expanding point‑of‑care testing.

3. What are the primary drivers fueling market expansion?

Key drivers include rising prevalence of chronic diseases requiring frequent monitoring, increased adoption of minimally invasive home‑testing kits, growing geriatric population, and healthcare providers’ shift toward rapid, low‑pain phlebotomy solutions, all of which boost demand for capillary needles.

4. What challenges could impede market growth?

Challenges comprise stringent regulatory approvals for needle safety, risk of needlestick injuries prompting stricter occupational health standards, price sensitivity in low‑income regions, and supply‑chain disruptions for high‑grade stainless steel, which together may constrain market momentum.

5. Which regions are leading the market?

North America remains the largest regional player, propelled by advanced healthcare infrastructure and high adoption of point‑of‑care devices. Europe follows closely, while Asia‑Pacific shows the fastest growth rate, driven by expanding middle‑class populations and increasing hospital networks.

6. Who are the top companies competing in this market?

Leading vendors include BD (Becton, Dickinson and Company), Terumo Corporation, Greiner Bio‑One, Medtronic, and Nipro Corporation, each offering differentiated needle designs, safety mechanisms, and integrated collection systems to capture market share across hospital, laboratory, and home‑care segments.

7. What future opportunities are emerging for the market?

Future outlook highlights opportunities in digital health integration, such as smart capillary needles equipped with sensors for real‑time hemoglobin analysis, and expansion into telemedicine platforms, where self‑collection kits can streamline remote diagnostics and broaden patient access.

8. How is technology reshaping the Capillary Blood Collection Needle market?

Advances in micro‑fabrication and polymer coating enable ultra‑thin, painless needles with enhanced blood flow, while automated collection devices reduce operator error. Additionally, integration with IoT platforms allows data transmission directly to electronic health records, improving clinical workflow efficiency.

9. What regulatory landscape governs these devices?

Capillary Blood Collection Needles are regulated under ISO 13485 quality standards and must comply with FDA 510(k) clearance in the United States, EU MDR 2021/830 in Europe, and respective national medical device directives, ensuring safety, sterility, and performance.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Capillary Blood Collection Needle Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Lifescan; BD; Ascensia; Abbott; B. Braun; ARKRAY; Terumo; I-SENS; Nipro; Omron; AgaMatrix; Smiths Medical; Sarstedt; Sinocare; Yicheng; Yuwell; Greiner Bio One
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options